Some gene mutations related to drug resistance have been detected in the relapse of pediatric ALL, including an increased function for NT5C2, loss of function for PRPS1, and loss of function for MSH6 related to thiopurine resistance. This evidence concerns the gene MSH6 and acute lymphoblastic leukemia.